Summary of Action investigated the marketing of Michigan-based “brain training” company Neurocore, LLC, and determined that the company has been engaged in an ongoing deceptive marketing campaign. Specifically, the company claims that its neurofeedback sessions can treat numerous medical conditions, including ADHD, anxiety, autism, depression, migraines, memory loss, and insomnia, without competent and reliable scientific evidence to support such treatment claims. Neurocore makes these claims throughout its marketing materials, including its website and social media pages, despite prior admonishment by the National Advertising Division (NAD) and the National Advertising Review Board (NARB), and the company’s representations that it would cease making such claims.

As a result of these findings, filed a complaint letter with the Federal Trade Commission on November 12, 2019 urging the agency to take action. On the same day, also filed a complaint letter with the U.S. Food and Drug Administration for the company’s marketing, use, and sale of unapproved medical devices due to the company’s failure to comply with FDA premarket notification procedures.

On April 22, 2020, the FTC informed the NARB (which had also referred the matter to the Commission after its own review) that it was closing out its investigation without enforcement action.

Check back for updates.

Print Friendly, PDF & Email

Tags: ,

Leave a Reply

Back to Top ↑